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Abstract 11 
This study quantified the changes of the frequency-dependant viscoelastic properties of the 12 
BDyn (S14 Implants, Pessac, France) spinal posterior dynamic stabilisation (PDS) device due 13 
to in vitro oxidation. Six polycarbonate urethane (PCU) rings and six silicone cushions were 14 
degraded by using a 20% hydrogen peroxide / 0.1M cobalt (II) chloride hexahydrate, at 37°C, 15 
for 24 days. The viscoelastic properties of the individual components and the components 16 
assembled into the BDyn PDS device were determined using Dynamic Mechanical Analysis 17 
at frequencies from 0.01–30 Hz. Attenuated Total Reflectance Fourier Transform Infra-Red 18 
spectra demonstrated chemical structure changes, of the PCU, associated with oxidation 19 
while Scanning Electron Microscope images revealed surface pitting. No chemical structure 20 
or surface morphology changes were observed for the silicone cushion. The BDyn device 21 
storage and loss stiffness ranged between 84.46 N/mm to 99.36 N/mm and 8.13 N/mm to 22 
21.99 N/mm, respectively. The storage and loss stiffness for the components and BDyn 23 
device increased logarithmically with respect to frequency. Viscoelastic properties, between 24 
normal and degraded components, were significantly different for specific frequencies only. 25 
This study demonstrates the importance of analysing changes of viscoelastic properties of 26 
degraded biomaterials and medical devices into which they are incorporated, using a 27 
frequency sweep.  28 
Keywords: BDyn Implant, Dynamic Mechanical Analysis, Oxidation, Posterior Dynamic 29 
Stabilisation, Viscoelastic Properties.  30 
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Introduction 31 
Spinal fusion is the gold standard for surgical treatment of low back pain caused by 32 
degenerative disorders (1)–(3). Many problems, such as adjacent segment degeneration and 33 
pseudarthrosis, are associated with spinal fusion and to alleviate these problems non-fusion 34 
techniques have been developed (4). The BDyn device (S14 Implants, Pessac, France) is a 35 
posterior dynamic stabilisation device that provides an alternative to spinal fusion. This non-36 
fusion device comprises a mobile titanium alloy rod, a fixed titanium alloy rod, a 37 
polycarbonate urethane (PCU) ring and a silicone cushion (figure 1). The BDyn device has 38 
been used in the treatment of degenerative lumbar spondylolisthesis (5) and an in vitro study 39 
has shown that the device can successfully limit the range of motion following a 40 
laminectomy of L4-L5 segment (6). 41 
Since the human lumbar spine has been reported to be resonant between 4–5 Hz in the 42 
seated position (7),(8), the frequency-dependent viscoelastic properties of the BDyn device, 43 
and its elastomeric components, were quantified by Dynamic Mechanical Analysis (DMA) (9). 44 
By applying an oscillating force to a multi-component structure and analysing the out-of-45 
phase displacement response, the storage (k’) and loss (k’’) stiffness were calculated to 46 
characterise the viscoelastic properties (10).  The storage stiffness represents the elastic 47 
portion and it defines the ability of a structure to store energy, while the loss stiffness 48 
describes the ability of the structure to dissipate energy through heat and internal motions 49 
(10). Lawless et al.(9) found that the viscoelastic properties of the BDyn device and its 50 
components were frequency dependent, for the frequency range 0.01-30 Hz, and no 51 
resonant frequencies were recorded for the device or its components over this frequency 52 
range.  53 
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The human body is an aggressive environment for biomaterials (11), thus, it is important that 54 
the materials of an implant can withstand the environment in the human body and not 55 
become degraded to a point where the implant cannot perform its intended function (12). 56 
Orthopaedic implants undergo numerous loads in a cyclical and potentially vibratory 57 
manner. Also, implants endure in vivo hydrolytic, enzymatic and oxidative degradation at 58 
body temperature. Oxidative degradation, the scission of the polymer chains through 59 
oxygen (13), has been shown to be an influence in the biodegradation of polyether urethane 60 
(PEU) and PCU (14). PCU has been stated to be more biostable (15) due to the removal of the 61 
ether linkages in the soft segment (14),(15). 62 
Numerous studies have used an in vitro degradation method, that involves placing the 63 
biomaterial into a 20% hydrogen peroxide (H2O2) and 0.1M cobalt chloride (CoCl2) solution 64 
at 37°C (16)–(22), to replicate oxidation. The Haber-Weiss chemical reaction produces hydroxyl 65 
radicals from this H2O2/CoCl2 solution and it is an appropriate model of the in vivo chemical 66 
reaction that produces oxygen radicals present at the polymer/cell interface (23). This in vitro 67 
method has been shown to reproduce chemical and physical degradation similar to in vivo 68 
oxidative degradation of PEU and PCU (14),(20). Further, this in vitro H2O2/CoCl2 solution has 69 
been commonly used to degrade polyether-urethane urea (PEUU), PEU, PCU and silicone 70 
modified PEU and PCU (16)–(18),(20),(21). Many of these studies focus on the degradation of films 71 
(16)–(18),(20),(21) or standard tensile specimen shapes (16) to understand how the degradation 72 
affects the mechanical behaviour of a material and not how degradation affects polymeric 73 
components of implants. 74 
The purpose of this study was to quantify the change in viscoelastic properties, using DMA, 75 
of elastomeric components from a BDyn device that have been degraded by in vitro 76 
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oxidation. Furthermore, these components were assembled into BDyn devices and 77 
comparisons were made between the degraded elastomeric components and the devices. 78 
Comparisons were made between the viscoelastic properties of the normal components (9) 79 
and the degraded components. 80 
Materials and methods 81 
Six silicone and six PCU components (figure 2) were obtained from S14 Implants (Pessac, 82 
France) and were used for a previous study (9). These components, which were sterilised 83 
with ethylene oxide (EtO) (Steriservices, Bernay, France) for the previous study, were 84 
degraded by using a 20% hydrogen peroxide (H2O2) and 0.1M cobalt (II) chloride 85 
hexahydrate (CoCl2.6H2O) oxidative solution. The in vitro accelerated ageing of the 86 
components was performed at 37°C in a Grant JBN18 water bath (Grant Instruments, 87 
Royston, UK). To maintain a relatively constant concentration of radicals, the solution was 88 
changed every 3 days and the degradation period lasted 24 days (17),(20). After the 89 
degradation period, the specimens were rinsed with water and were dried in a vacuum 90 
chamber (Island Scientific Ltd., Ventnor, United Kingdom) for 48 hours at room 91 
temperature.  92 
The viscoelastic properties of the degraded components were measured using a Bose 93 
ElectroForce 3200 testing machine running WinTest 4.1 DMA software (now, TA 94 
Instruments, New Castle, DE, USA). The DMA technique, machine and software have been 95 
used to quantify the storage and loss stiffness of a posterior dynamic stabilisation device, its 96 
components (9) and various biological tissues (24),(25). 97 
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Similar to the previous study (9), custom-designed grips were used to clamp the titanium 98 
alloy rods and/or titanium alloy elastomer housing of the BDyn device. The devices were 99 
secured by twelve horizontal screws. The order of component testing was randomised by 100 
using the Excel Random Function (Redmond, Washington, USA). The degraded components 101 
were then paired randomly and tested in the BDyn device. For testing of the BDyn 1 level, 102 
the titanium alloy mobile and fixed rods were gripped. Since the BDyn device is designed to 103 
work in both tension and compression, a sinusoidally varying load between +20 N (tension) 104 
and -20 N (compression) was applied to the devices. As the components are only loaded in 105 
compression, a sinusoidally varying load between -1 N and -20 N (compression) was applied 106 
to the elastomeric components. Testing the device and components to these ranges gave a 107 
direct comparison between the degraded components, the device and the previous study (9). 108 
Initially, the degraded individual components were tested then the PCU and silicone 109 
components were randomly paired, assembled in the BDyn titanium housing and tested. All 110 
testing was performed, in air at 37°C ± 1°C, in a custom built chamber in which water was 111 
pumped around the chamber while the air temperature was monitored throughout the 112 
frequency sweep (figure 3).  113 
The storage and loss stiffness were calculated for 21 different frequencies from 0.01 Hz to 114 
30 Hz; this range is comparable to that of a previous study of the BDyn components (9). For 115 
each frequency (f), a Fourier analysis of the force and displacement waves was performed 116 
and the magnitude of the load (F*), magnitude of the displacement (d*), the phase lag (δ) 117 
and the actual frequency were quantified (9). The complex stiffness (k*), storage stiffness (k’) 118 
and loss stiffness (k’’) were then calculated using (9),(26),(27):   119 
   𝑘∗ =
𝐹∗
𝑑∗
     (1) 120 
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𝑘′ = 𝑘∗ cos 𝛿     (2) 121 
𝑘′′ = 𝑘∗ sin 𝛿     (3)  122 
Attenuated Total Reflectance Fourier Transform Infra-Red (ATR-FTIR) spectroscopy was then 123 
performed using a Bruker LUMOS spectrometer (Bruker Optics, Billerica, MA, USA). Spectra 124 
were recorded in absorbance mode with a Germanium ATR crystal. Twenty spectra, with a 125 
resolution of 2 cm-1 between 600 and 4000 cm-1, were acquired and averaged to obtain each 126 
spectrum (28). The PCU spectra were normalised to the internal reference 1591 cm-1 peak, 127 
the C=C bond stretch of the aromatic ring of the hard segment (20),(29)–(31), which has been 128 
shown to remain unchanged in degradation (32).  129 
The surface morphology of the elastomers was examined using the Hitachi TM3030 130 
Scanning Electron Microscope (SEM) (Chiyoda, Tokyo, Japan). Specimens were sputter 131 
coated with ~30 nm layer of gold by using an Agar B7340 sputter coater (Agar Scientific, 132 
Stansted, Essex, UK). The specimens were examined with back-scatter detector at a 15 keV 133 
accelerating voltage. 134 
All statistical analyses were performed using SigmaPlot 13.0 (SYSTAT, San Jose, CA, USA). 135 
95% confidence intervals were calculated (n = 6) and regression analyses were performed to 136 
evaluate the significance of the curve fit. Wilcoxon signed rank tests were performed to 137 
compare the differences of the components before and after degradation. Whereas a 138 
Wilcoxon rank sum test compared the normal BDyn viscoelastic properties (9) to the BDyn 139 
device assembled with the degraded components. Statistical results with p < 0.05 were 140 
considered significant. 141 
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Results 142 
The ATR-FTIR spectrum, of the PCU and silicone components, is illustrated in figure 4 and 143 
figure 5, respectively. Evidence of crosslinking of the PCU has been established as a new 144 
absorbance peak was observed at 1174 cm-1. The PCU degraded specimens also showed 145 
hard segment degradation with the presence of a new aromatic amine group at 1650 cm-1. 146 
There was no evidence of changes to the chemical structure of the degraded silicone 147 
specimens (figure 5). 148 
Representative SEM images of the surfaces of the PCU and silicone components are shown 149 
in figure 6 and figure 7, respectively. The PCU specimens degraded for 24 days 150 
demonstrated surface pitting.  There was no evidence of surface pitting, or any other 151 
surface morphology changes, with the degraded silicone specimens. 152 
Figure 8 presents the storage stiffness of the (a) BDyn implant, (b) PCU component and (c) 153 
silicone component, for normal and degraded components. The mean degraded PCU and 154 
silicone components storage stiffness ranged between 87.5 N/mm to 135.3 N/mm and 51.6 155 
N/mm to 60.7 N/mm, respectively. The BDyn implant storage stiffness ranged between 156 
84.46 N/mm to 99.36 N/mm. The storage stiffness logarithmically increased in relation to 157 
frequency (p < 0.05) (equation 4, where A is a coefficient and B is a constant, and Table 1). 158 
 𝑘′ = 𝐴 ln(𝑓) + 𝐵   for  0.01 ≤ 𝑓 ≤ 30  (4) 159 
Figure 9 exhibits the normal and degraded loss stiffness for the (a) BDyn implant, (b) PCU 160 
component and (c) silicone component. The degraded PCU and silicone components loss 161 
stiffness ranged between 6.03 N/mm to 24.45 N/mm and 4.59 N/mm to 10.83 N/mm, 162 
respectively. The BDyn implant loss stiffness ranged between 8.13 N/mm to 21.99 N/mm. 163 
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Similarly to the storage stiffness, the loss stiffness logarithmically increased in relation to 164 
frequency (p < 0.05) (equation 5, where C is a coefficient and D is a constant, and Table 1). 165 
𝑘′′ = 𝐶 ln(𝑓) + 𝐷   for  0.01 ≤ 𝑓 ≤ 30  (5)     166 
For the PCU component, silicone component and BDyn implant assembled with the 167 
degraded components, the storage stiffness was larger than the loss stiffness for all 168 
frequencies tested. Table 2 provides the frequencies at which the PCU and silicone 169 
components were significantly different before and after degradation. The storage and loss 170 
stiffness of the silicone component, before and after degradation, were significantly 171 
different for the frequency range tested while the PCU component loss stiffness was only 172 
significantly different for certain frequencies; 0.5 Hz, 4 Hz to 30 Hz. Also, the storage 173 
stiffness of the BDyn device, assembled with degraded components, was significantly 174 
different from 0.2 Hz to 20 Hz while, the loss stiffness was significantly different from 0.01 175 
Hz to 0.3 Hz and 0.5 Hz to 15 Hz. 176 
Discussion 177 
This study has quantified the frequency-dependent viscoelastic properties of a posterior 178 
dynamic stabilisation device with in vitro oxidative degraded components. The degraded 179 
components and BDyn device, with the degraded components, were viscoelastic throughout 180 
the frequency range tested. The degraded BDyn 1 level device storage stiffness and loss 181 
stiffness were less than the storage stiffness (95.56 N/mm to 119.29 N/mm) and loss 182 
stiffness (10.72 N/mm to 23.42 N/mm) (9) for the normal BDyn 1 level device. However, the 183 
reductions in viscoelastic properties of the PCU and silicone components, due to the in vitro 184 
degradation process, are significantly different for specific frequencies. Subsequently, the 185 
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storage and loss stiffness of the BDyn device assembled with in vitro degraded components 186 
were lower than those of the untreated device (9) only for specific frequencies. These 187 
findings demonstrate the importance of analysing changes of viscoelastic properties of 188 
specimens over a frequency sweep. 189 
The mean storage stiffness and mean loss stiffness trends of the BDyn device and 190 
components followed a logarithmic increasing trend with frequency; these trends are 191 
similar to the normal, untreated specimens (9). This is deemed a positive result as the 192 
degradation did not affect the frequency-dependant behaviour of the components or 193 
device. However, the logarithmic equation coefficients (A and C) and constants (B and D) of 194 
the degraded specimens were lower than the normal specimens (9). Similarly to the normal 195 
BDyn implant and components (9), no resonant frequencies were identified for the degraded 196 
components and implant with degraded components. Previous studies (33),(34) have also 197 
shown that the lumbar specimens did not exhibit shock absorbing properties, in pure 198 
compression, as no sharp peak detected in the loss modulus for the frequency range (33).  199 
Panjabi et al. (7) recorded the average in vivo lumbar vertebrae resonant frequency at 4.4 Hz 200 
for the axial direction, in the seated position. Wilder et al. (8) recorded the greatest 201 
transmissibility in the male and female lumbar spine of 4.9 Hz and 4.75 Hz, respectively, and 202 
also recorded two further resonant frequencies at 9.5 Hz and 12.7 Hz. Any resonance, of the 203 
device, at any frequency is a limitation of the device as the resonance may damage the 204 
device and in a worst case scenario, the device may fail (9). 205 
Other studies have examined the effect of in vitro oxidative degradation in relation to 206 
tensile strain (16),(22),(31) and Dynamic Mechanical Thermal Analysis (DMTA) (17),(35), but not 207 
DMA. After 36 days of in vitro oxidation, Dempsey et al. (16) stated that the ultimate tensile 208 
11 
 
strength of Bionate 80A, a PCU, was less when compared to the untreated specimens. 209 
However, the ultimate tensile strength of Bionate II 80A was greater for the specimens that 210 
were treated; the percentage elongation of Bionate 80A and Bionate II 80A increased by 2-211 
3% after oxidation (16). Schubert et al. (21) discovered a 10% decrease in stress at high strains 212 
of treated PEUU specimens when compared to the untreated PEUU specimens. This result 213 
was similar to those of Christenson et al. (20) who found a minor decrease in stress at high 214 
strains when comparing the tensile stress-strain behaviour of in vitro oxidised PEU and PCU 215 
to untreated PEU and PCU. Apart from this decrease in stress, the Young’s modulus was 216 
unaffected (20).  By using DMTA, Wu et al. (35) investigated the biostability of polyether 217 
urethane urea (PEUU) blood sacs and proposed a greater degree of phase separation 218 
between hard and soft segments of the implanted sacs due to the α transition shift of -15°C, 219 
compared to the control. Hernandez et al. (17) discovered that the maximum loss factor (tan 220 
δ), of a PCU, reduced by approximately 0.05 while the storage modulus did not appreciably 221 
change after oxidation. From this, the author suggested that there was no significant 222 
changes in the hard-soft segment organisation in the bulk (17). This lack of appreciable 223 
change is similar to the present study as the storage stiffness, of the PCU, was not 224 
significantly different following degradation over the frequency range tested. However, in 225 
the present study, the viscous property (loss stiffness), of the PCU component, was affected 226 
by in vitro oxidation at 0.5 Hz and from 4 Hz to 30 Hz. This demonstrates the importance of 227 
understanding the viscoelastic properties of components and implants in relation to 228 
frequency.  229 
Christenson et al. (20) demonstrated that in vitro degradation of PEU and PCU, with the 20% 230 
hydrogen peroxide (H2O2) and 0.1M cobalt chloride (CoCl2) solution at 37 °C for 24 days, led 231 
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to surface pitting and ATR-FTIR spectra changes. Such changes were similar to explanted 232 
PCU rods from rabbits after 15 months and PCU specimens from rats after 20 weeks (31). 233 
From the ATR-FTIR spectrum, a decrease in absorbance peak intensity at 1247 cm-1 was 234 
observed for the degraded PCU; this decrease, along with the new absorbance peak at 1174 235 
cm-1 provides evidence of chain scission and crosslinking of the soft segment (17),(20),(36). A 236 
decrease of the degraded PCU hard segment urethane intensity and a new absorbance peak 237 
at 1650 cm-1 (the potential degradation product of the aromatic amine(31)) provides 238 
evidence of hard segment chain scission (20),(23),(30). These spectrum changes are similar to 239 
previous work (20),(30) however, the new peaks observed at 1174 cm-1 and 1650 cm-1 are not 240 
as prominent as previous studies (20),(18) and this may be due to the antioxidant inhibitor 241 
used in this commercially available PCU. This inhibitor will have had an effect on the 242 
degradation and, in turn, the absorbance peaks at 1174 cm-1 and 1650 cm-1. However, the 243 
degraded PCU ATR-FTIR spectrum absorbance peaks at 1174 cm-1 and 1650 cm-1, from our 244 
current study, are similar to another study (16) that degraded PCU specimens with an 245 
accelerated oxidation method for 36 days. In the present study, SEM images revealed pitting 246 
on the surface of the PCU components which has been previously documented for in vitro 247 
and in vivo oxidation of PCU (16),(31).  248 
Explanted orthopaedic implants, which contain PCU components, have demonstrated new 249 
absorbance peaks at 1650 cm-1 and/or 1174 cm-1 to demonstrate biological oxidative 250 
degradation (37)–(39).  However, another explant study did not find new absorbance peaks 251 
linked to biological oxidative degradation (40). Ianuzzi et al. (39) stated that the majority of the 252 
PCU spacers, exhibiting a chemical change associated with biodegradation, experienced this 253 
degradation on the surface where the spacer would make contact with tissue. Examination 254 
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of retrieved PCU spacers revealed that chemical changes were negligible 100 μm below the 255 
surface (41). The elastomeric components of the BDyn device are surrounded by titanium 256 
alloy housing (see figure 2). In this study, the components were completely exposed to the 257 
H2O2/CoCl2 solution without taking into account the effect of the titanium alloy housing. It is 258 
hypothesised that the titanium housing will have an effect on the degradation of the 259 
polymer components. The titanium alloy housing may protect the components from 260 
biodegradation, or alternatively, additional titanium alloy may increase metal ion oxidation 261 
(MIO).  262 
Silicone has demonstrated excellent biostability with no identifiable in vivo degradation (42) 263 
and due to this excellent biostability, silicone has been used to modify PEU and PCU to 264 
increase the biostability with the intention to inhibit degradation. The oxidation method, 265 
used in this study, has been previously used to understand how degradation affects 266 
PCU/PEU (16)–(18),(20),(21) and PCU/PEU modified with silicone (18). In comparison to unmodified 267 
PEU and PCU, the percent loss of silicone-modified PEU and PCU soft-segment was less than 268 
the unmodified PEU and PCU; this may be an indication of slower rates of crosslinking due 269 
to the addition on silicone (18). The H2O2/CoCl2 in vitro method has been shown to reproduce 270 
chemical and physical degradation similar to in vivo oxidative degradation of PEU and PCU 271 
(14),(20), but not for silicone. It was expected that there would be no significant change in the 272 
viscoelastic properties of the silicone cushion, by using this H2O2/CoCl2 degradation method. 273 
However, the storage and loss stiffness of the treated silicone component was significantly 274 
different, for every frequency tested, when compared to viscoelastic properties before 275 
degradation. That said, there were no changes evident in the ATR-FTIR spectra and unlike 276 
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the PCU ring, no pitting or surface morphology changes were observed for the silicone 277 
cushions.  278 
As the dynamic stiffness can be affected by load (43), any comparison between different 279 
methods and studies must be made with caution (9). For consistency to our previous study, 280 
the methods all remained unchanged with the only change being the degradation of the 281 
PCU and silicone components; this was important to understand how the in vitro 282 
degradation process affects the frequency dependent viscoelastic properties. Regardless, no 283 
in vitro degradation method fully replicates the biochemical and biomechanical stresses 284 
experienced in the body (42). Consistent with our previous study, the DMA test configuration 285 
is not similar to the in vivo scenario where the mobile and fixed rods are secured to the 286 
pedicles(9). By securing the mobile rod to the vertebra, an applied load to the device may not 287 
displace the two polymer systems equally; hence, the difference in displacement will affect 288 
the dynamic stiffness (k*) and in turn, the storage (k’) and loss (k’’) stiffness (9). The BDyn 289 
device is designed to allow partial movement along the anatomical planes(9). This study 290 
quantified the viscoelastic properties of the degraded BDyn components, and the degraded 291 
components in the device, uniaxially. Rotation of the moveable rod, around an anatomical 292 
plane, may affect the response of the out-of-phase displacement to an applied force and 293 
hence, affect the viscoelastic properties (9). However, these limitations do not alter the 294 
conclusions of this study because the sinusoidally applied loads ensured a direct comparison 295 
between the normal and degraded components and implant.  296 
In conclusion, two viscoelastic components of a spinal posterior dynamic stabilisation device 297 
were treated by an in vitro oxidation method. Only the PCU components displayed changes 298 
to their chemical structure and exhibited surface morphology changes. The loss stiffness, 299 
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between normal and degraded components, of the PCU component were significantly 300 
different for specific frequencies while the storage and loss stiffness of the silicone 301 
component were significantly different for all frequencies tested. When compared to the 302 
untreated BDyn device, the storage and loss stiffness of the BDyn device assembled with the 303 
in vitro degraded components were statistically different for certain frequencies. This study 304 
demonstrates the importance of analysing changes of viscoelastic properties, of degraded 305 
biomaterials, in terms of frequency and medical devices into which they are incorporated, 306 
using a frequency sweep.  307 
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Figure Legends  438 
 439 
Figure 1: BDyn 1 level device fixed to the vertebrae (Left) [Reproduced with kind permission 440 
from S14 Implants, Pessac, France. © S14 Implants] and cross sectional view of the BDyn 441 
device (Right). The polycarbonate urethane (PCU) ring and silicone cushion components, 442 
along with the mobile and fixed rods, are highlighted. 443 
  444 
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 445 
 446 
Figure 2: PCU components, (A) before and (B) after degradation, and silicone components 447 
(C) before and (D) after degradation. The normal PCU and silicone components are used in 448 
the BDyn device. 449 
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 452 
Figure 3: Testing of BDyn 1 device with degraded elastomer components in the custom built 453 
chamber  454 
 455 
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 456 
Figure 4: Stacked ATR-FTIR spectra of PCU components before (Normal) and after 457 
(Degraded) in vitro oxidative degradation 458 
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 460 
Figure 5: Stacked ATR-FTIR spectra of silicone components before (Normal) and after 461 
(Degraded) in vitro oxidative degradation 462 
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 464 
Figure 6: Scanning electron micrographs of PCU components before, at (A) ⨯1.2k and (B) 465 
⨯2.0k magnification, and after, at (C) ⨯1.2k and (D) ⨯2.0k magnification, in vitro oxidative 466 
degradation  467 
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 470 
Figure 7: Scanning electron micrographs of silicone components before, at (A) ⨯1.2k and (B) 471 
⨯2.0k magnification, and after, at (C) ⨯1.2k and (D) ⨯2.0k magnification, in vitro oxidative 472 
degradation  473 
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 475 
Figure 8: Storage stiffness (k’) against ln(f) for (a) normal and degraded BDyn device (BDyn), 476 
(b) normal and degraded polycarbonate urethane (PCU)  component (PCU) and (c) normal 477 
and degraded silicone (Sil) component (mean ± 95% confidence intervals). Normal data is 478 
from a previous study (9). 479 
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 481 
Figure 9: Loss stiffness (k’’) against ln(f) for (a) normal and degraded BDyn device (BDyn), (b) 482 
normal and degraded polycarbonate urethane (PCU)  component (PCU) and (c) normal and 483 
degraded silicone (Sil) component (mean ± 95% confidence intervals). Normal data is from a 484 
previous study (9). 485 
 486 
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Table 1: Storage stiffness (equation 4) and loss stiffness (equation 5) regression analyses of the BDyn devices 488 
and its components. Cofficients (A, B, C and D) for the individual specimens’ storage and loss stiffness 489 
(N/mm) trends are provided. 490 
 
 
 
k' = Aln(f)+B 
 
k'' = Cln(f)+D 
Specimen ID A B r² P Value 
 
C D r² P Value 
BDyn 1 – 1  2.7 105.1 0.93 <0.001 
 
1.7 16.4 0.90 <0.001 
BDyn 1 – 2  1.3 87.0 0.81 <0.001 1.2 11.1 0.80 <0.001 
BDyn 1 – 3  1.2 89.6 0.96 <0.001  1.4 14.6 0.81 <0.001 
BDyn 1 – 4  0.8 85.1 0.64 <0.001  1.2 11.0 0.82 <0.001 
BDyn 1 – 5  3.1 99.4 0.87 <0.001  1.8 15.2 0.80 <0.001 
BDyn 1 – 6  1.3 80.3 0.97 <0.001  1.1 8.9 0.77 <0.001 
BDyn 1 - Mean  1.7 91.1 0.97 <0.001  1.4 12.9 0.82 <0.001 
PCU – 1   6.3 102.7 0.94 <0.001 
 
2.7 14.3 0.90 <0.001 
PCU – 2  6.8 123.0 0.96 <0.001 
 
2.5 14.6 0.89 <0.001 
PCU – 3  6.3 118.8 0.96 <0.001 
 
2.3 13.7 0.89 <0.001 
PCU – 4  5.2 101.2 0.96 <0.001 
 
1.9 11.3 0.88 <0.001 
PCU – 5  5.8 107.5 0.95 <0.001 
 
2.1 12.9 0.89 <0.001 
PCU – 6 5.1 101.5 0.96 <0.001 
 
1.9 11.3 0.89 <0.001 
PCU – Mean  5.9 109.1 0.95 <0.001 2.2 13.0 0.89 <0.001 
Silicone – 1   1.1 52.5 0.96 <0.001 
 
0.6 6.2 0.93 <0.001 
Silicone – 2  1.5 63.7 0.97 <0.001 
 
0.9 9.5 0.96 <0.001 
Silicone – 3  0.7 45.3 0.90 <0.001 
 
0.6 6.0 0.90 <0.001 
Silicone – 4  1.4 62.2 0.97 <0.001 
 
0.7 7.6 0.95 <0.001 
Silicone – 5  1.1 53.4 0.96 <0.001 
 
0.7 6.5 0.93 <0.001 
Silicone – 6 1.2 59.4 0.96 <0.001 
 
0.7 7.8 0.95 <0.001 
Silicone - Mean  1.2 56.1 0.97 <0.001 0.7 7.3 0.94 <0.001 
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Table 2: Wilcoxon Signed Rank test results for the PCU and Silcone components and Wilcoxon Rank Sum test 493 
for the BDyn Device. The frequencies stated indicates a significantly different (p < 0.05) between the 494 
untreated and degraded specimens. 495 
Component Storage Stiffness Loss Stiffness 
PCU - 0.5 Hz, 4 Hz to 30 Hz 
Silicone 0.01 Hz to 30 Hz 0.01 Hz to 30 Hz 
BDyn Device 0.2 Hz to 20 Hz 0.01 Hz to 0.3 Hz, 0.5 Hz to 15 Hz 
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